AMPK signaling in cancer: Molecular insights and therapeutic opportunities
Cancer Letters · 2026-12 · 662 · 218912
DOI: 10.1016/j.canlet.2026.218912 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-12. Verfasst von Weiwei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction, AMP-Activated Protein Kinases. Die Arbeit nennt 171 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
AMP-activated protein kinase (AMPK) is a highly conserved serine/threonine kinase regarded as an indispensable energy sensor during metabolic stress, coordinating diverse biological processes, including glycolysis, the tricarboxylic acid (TCA) cycle, mitochondrial dynamics, and multiple stress-responsive signaling pathways. Growing evidence shows that dysregulated AMPK signaling plays closely linked roles in tumorigenesis. Depending on the context, AMPK signaling can suppress or promote tumor growth. Mechanistically, dysregulated AMPK kinase activity contributes to metabolic reprogramming, mitochondrial dysfunction, and epigenetic alterations, all recognized hallmarks of cancer. Consequently, targeting AMPK signaling has emerged as a promising strategy for cancer therapy. In this review, we summarize the molecular mechanisms regulating AMPK signaling, discuss its dual functions in tumor biology, highlight recent advances in AMPK-targeted therapeutic strategies, and address current challenges and future perspectives for the clinical translation of AMPK-targeted cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
- Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: wwei2@bidmc.harvard.edu.
Förderung
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
Zitieren
APA
Jiang, W., Yan, P., Wang, J., Xue, X., Huang, D., Chen, L., Yang, Y., Inuzuka, H., & Wei, W. (2026). AMPK signaling in cancer: Molecular insights and therapeutic opportunities. Cancer Letters, 662, 218912. https://doi.org/10.1016/j.canlet.2026.218912
Vancouver
Jiang W, Yan P, Wang J, Xue X, Huang D, Chen L, et al. AMPK signaling in cancer: Molecular insights and therapeutic opportunities. Cancer Letters. 2026;662:218912. doi:10.1016/j.canlet.2026.218912
BibTeX
@article{Jiang2026,
author = {Jiang, Weiwei and Yan, Peiqiang and Wang, Jingchao and Xue, Xutong and Huang, Daoyuan and Chen, Li and Yang, Yuelin and Inuzuka, Hiroyuki and Wei, Wenyi},
title = {AMPK signaling in cancer: Molecular insights and therapeutic opportunities},
journal = {Cancer Letters},
year = {2026},
volume = {662},
pages = {218912},
doi = {10.1016/j.canlet.2026.218912}
}
EUVIMED